Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Quality of Life Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa in People with Parkinson's

              Author:Verhagen Metman, Leonard   Pahwa, Rajesh   Kimber, Thomas   Vaou, Okeanis   Homola, Jaclyn   Bergmann, Lars   Jia, Jia   Shah, Megha   Aldred, Jason   

              Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

              Topic:Movement Disorders  

              Program Number:P9.003  

              Author Institution:Northwestern University, Chicago, IL, USA, Chicago, IL  University of Kansas Medical Center, Kansas City, KS, USA, Kansas City, KS  Royal Adelaide Hospital, Adelaide, SA, Australia, Beulah Park, Australia  University of Texas Health Science Center at San Antonio, San Antonio, TX, USA, San Antonio, TX  AbbVie Inc., North Chicago, IL, USA, Elk Grove Village, IL  AbbVie Inc., North Chicago, IL, USA, Ludwigshafen, Germany  AbbVie Inc., North Chicago, IL, USA, Lincolnshire, IL  AbbVie Inc., North Chicago, IL, USA, Detroit, MI  Selkirk Neurology & Inland Northwest Research, Spokane, WA, USA, Spokane, WA  

              Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa on Sleep Dysfunction in People with Parkinson's

              Author:Hauser, Robert   Bergmans, Bruno   Malaty, Irene   Cobb, Daniel   Homola, Jaclyn   Bergmann, Lars   Gupta, Resmi   Jia, Jia   Shah, Megha   Chaudhuri, K Ray   

              Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

              Topic:Movement Disorders  

              Program Number:P9.005  

              Author Institution:University of South Florida, Tampa, FL, USA, Tampa, FL  AZ St-Jan Brugge-Oostende AV, Brugge, Belgium and Ghent University Hospital, Ghent, Belgium, Bruges, Belgium  University of Florida, Gainesville, FL, USA, Gainesville, FL  Neurological Center of North Georgia, LLC, Gainesville, GA, USA, Gainesville, GA  AbbVie Inc., North Chicago, IL, USA, Elk Grove Village, IL  AbbVie Inc., North Chicago, IL, USA, Ludwigshafen, Germany  AbbVie Inc., North Chicago, IL, USA, Sugar Land, TX  AbbVie Inc., North Chicago, IL, USA, Lincolnshire, IL  AbbVie Inc., North Chicago, IL, USA, Detroit, MI  King's College Hospital, London, UK, London, United Kingdom  

              Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Motor Fluctuations in Parkinson’s Disease

              Author:Fung, Victor   Bergquist, Filip   Dhanani, Sara   Facheris, Maurizio   Gandor, Florin   Isaacson, Stuart   Jeong, Anna   Jia, Jia   Spiegel, Amy   Aldred, Jason   

              Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

              Topic:Movement Disorders  

              Program Number:P9.008  

              Author Institution:Department of Neurology, Westmead Hospital, Sydney, NSW, Australia and Sydney Medical School, Sydney, NSW, Australia, Sydney, Australia  Department of Pharmacology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden, Gothenburg, Sweden  Banner Sun Health Research Institute, Sun City, AZ, USA, Sun City, AZ  AbbVie Inc., North Chicago, IL, USA, North Chicago, IL  Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany and Movement Disorders Hospital, Beelitz-Heilstätten, Germany, Magdeburg, Germany  Parkinson’s Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL, USA, Boca Raton, FL  AbbVie Inc., North Chicago, IL, USA, Lincolnshire, IL  Selkirk Neurology and Inland Northwest Research, Spokane, WA, USA, Spokane, WA